Harnessing Open-Source Solutions: Insights From the First Open Systems Pharmacology (OSP) Community Conference.
Saved in:
| Title: | Harnessing Open-Source Solutions: Insights From the First Open Systems Pharmacology (OSP) Community Conference. |
|---|---|
| Authors: | Dallmann A; Bayer HealthCare SAS, Lille, France., Feick D; DMPK Modeling & Simulation, Sanofi R&D, Frankfurt am Main, Germany., Balazki P; ESQlabs GmbH, Saterland, Germany., Benamara S; Computational Pharmacology and Clinical Oncology, Inserm UMR1068, CNRS, Aix Marseille University, Marseille, France.; Translational Medicine & Early Development, Sanofi R&D, Vitry-sur-Seine, France., Burghaus R; Model-Informed Drug Development, Research & Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany., Chenel M; Pharmetheus AB, Uppsala, Sweden., Choi SL; DMPK Modeling & Simulation, Sanofi-Aventis R&D, Vitry-sur-Seine, France., Cordes H; DMPK Modeling & Simulation, Sanofi R&D, Frankfurt am Main, Germany., Guimarães M; ESQlabs GmbH, Saterland, Germany., Hamadeh A; School of Pharmacy, University of Waterloo, Kitchener, Ontario, Canada., Ince I; Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & co. KG, Ingelheim am Rhein, Germany., Job KM; Division of Clinical Pharmacology, Department of Pediatrics, School of Medicine, The University of Utah, Salt Lake City, Utah, USA., Kanacher T; Pharmetheus AB, Uppsala, Sweden., Kovar A; DMPK Modeling & Simulation, Sanofi R&D, Frankfurt am Main, Germany., Kuepfer L; Institute for Systems Medicine With Focus on Organ Interaction, University Hospital RWTH Aachen, Aachen, Germany., Lippert J; Model-Informed Drug Development, Research & Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany., Macente J; Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium., Nauwelaerts N; ESQlabs GmbH, Saterland, Germany.; Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium., Niederalt C; Model-Informed Drug Development, Research & Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany., Peters S; Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & co. KG, Ingelheim am Rhein, Germany., Proença S; ESQlabs GmbH, Saterland, Germany., Sato M; Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & co. KG, Ingelheim am Rhein, Germany., Schaller S; ESQlabs GmbH, Saterland, Germany., Schlender JF; Biomedical Research, Novartis, Basel, Switzerland., Schneider A; Model-Informed Drug Development, Research & Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany., Sjögren E; Pharmetheus AB, Uppsala, Sweden.; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden., Solodenko J; Model-Informed Drug Development, Research & Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany., Staab A; Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & co. KG, Ingelheim am Rhein, Germany., Vrenken P; National and Kapodistrian University of Athens, Department of Pharmacy, Zografou, Greece., Wendl T; Model-Informed Drug Development, Research & Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany., de Witte WEA; ESQlabs GmbH, Saterland, Germany., Teutonico D; Translational Medicine & Early Development, Sanofi R&D, Vitry-sur-Seine, France. |
| Source: | CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2025 May; Vol. 14 (5), pp. 822-827. Date of Electronic Publication: 2025 Apr 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101580011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2163-8306 (Electronic) Linking ISSN: 21638306 NLM ISO Abbreviation: CPT Pharmacometrics Syst Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40178335 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Harnessing Open-Source Solutions: Insights From the First Open Systems Pharmacology (OSP) Community Conference. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Dallmann+A%22">Dallmann A</searchLink>; Bayer HealthCare SAS, Lille, France.<br /><searchLink fieldCode="AU" term="%22Feick+D%22">Feick D</searchLink>; DMPK Modeling & Simulation, Sanofi R&D, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Balazki+P%22">Balazki P</searchLink>; ESQlabs GmbH, Saterland, Germany.<br /><searchLink fieldCode="AU" term="%22Benamara+S%22">Benamara S</searchLink>; Computational Pharmacology and Clinical Oncology, Inserm UMR1068, CNRS, Aix Marseille University, Marseille, France.; Translational Medicine & Early Development, Sanofi R&D, Vitry-sur-Seine, France.<br /><searchLink fieldCode="AU" term="%22Burghaus+R%22">Burghaus R</searchLink>; Model-Informed Drug Development, Research & Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany.<br /><searchLink fieldCode="AU" term="%22Chenel+M%22">Chenel M</searchLink>; Pharmetheus AB, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Choi+SL%22">Choi SL</searchLink>; DMPK Modeling & Simulation, Sanofi-Aventis R&D, Vitry-sur-Seine, France.<br /><searchLink fieldCode="AU" term="%22Cordes+H%22">Cordes H</searchLink>; DMPK Modeling & Simulation, Sanofi R&D, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Guimarães+M%22">Guimarães M</searchLink>; ESQlabs GmbH, Saterland, Germany.<br /><searchLink fieldCode="AU" term="%22Hamadeh+A%22">Hamadeh A</searchLink>; School of Pharmacy, University of Waterloo, Kitchener, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Ince+I%22">Ince I</searchLink>; Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & co. KG, Ingelheim am Rhein, Germany.<br /><searchLink fieldCode="AU" term="%22Job+KM%22">Job KM</searchLink>; Division of Clinical Pharmacology, Department of Pediatrics, School of Medicine, The University of Utah, Salt Lake City, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Kanacher+T%22">Kanacher T</searchLink>; Pharmetheus AB, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Kovar+A%22">Kovar A</searchLink>; DMPK Modeling & Simulation, Sanofi R&D, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Kuepfer+L%22">Kuepfer L</searchLink>; Institute for Systems Medicine With Focus on Organ Interaction, University Hospital RWTH Aachen, Aachen, Germany.<br /><searchLink fieldCode="AU" term="%22Lippert+J%22">Lippert J</searchLink>; Model-Informed Drug Development, Research & Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany.<br /><searchLink fieldCode="AU" term="%22Macente+J%22">Macente J</searchLink>; Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Nauwelaerts+N%22">Nauwelaerts N</searchLink>; ESQlabs GmbH, Saterland, Germany.; Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Niederalt+C%22">Niederalt C</searchLink>; Model-Informed Drug Development, Research & Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany.<br /><searchLink fieldCode="AU" term="%22Peters+S%22">Peters S</searchLink>; Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & co. KG, Ingelheim am Rhein, Germany.<br /><searchLink fieldCode="AU" term="%22Proença+S%22">Proença S</searchLink>; ESQlabs GmbH, Saterland, Germany.<br /><searchLink fieldCode="AU" term="%22Sato+M%22">Sato M</searchLink>; Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & co. KG, Ingelheim am Rhein, Germany.<br /><searchLink fieldCode="AU" term="%22Schaller+S%22">Schaller S</searchLink>; ESQlabs GmbH, Saterland, Germany.<br /><searchLink fieldCode="AU" term="%22Schlender+JF%22">Schlender JF</searchLink>; Biomedical Research, Novartis, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Schneider+A%22">Schneider A</searchLink>; Model-Informed Drug Development, Research & Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany.<br /><searchLink fieldCode="AU" term="%22Sjögren+E%22">Sjögren E</searchLink>; Pharmetheus AB, Uppsala, Sweden.; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Solodenko+J%22">Solodenko J</searchLink>; Model-Informed Drug Development, Research & Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany.<br /><searchLink fieldCode="AU" term="%22Staab+A%22">Staab A</searchLink>; Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & co. KG, Ingelheim am Rhein, Germany.<br /><searchLink fieldCode="AU" term="%22Vrenken+P%22">Vrenken P</searchLink>; National and Kapodistrian University of Athens, Department of Pharmacy, Zografou, Greece.<br /><searchLink fieldCode="AU" term="%22Wendl+T%22">Wendl T</searchLink>; Model-Informed Drug Development, Research & Development, Pharmaceuticals, Bayer AG, Leverkusen, Germany.<br /><searchLink fieldCode="AU" term="%22de+Witte+WEA%22">de Witte WEA</searchLink>; ESQlabs GmbH, Saterland, Germany.<br /><searchLink fieldCode="AU" term="%22Teutonico+D%22">Teutonico D</searchLink>; Translational Medicine & Early Development, Sanofi R&D, Vitry-sur-Seine, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101580011%22">CPT: pharmacometrics & systems pharmacology</searchLink> [CPT Pharmacometrics Syst Pharmacol] 2025 May; Vol. 14 (5), pp. 822-827. <i>Date of Electronic Publication: </i>2025 Apr 03. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101580011 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2163-8306 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221638306%22">21638306 </searchLink><i>NLM ISO Abbreviation: </i>CPT Pharmacometrics Syst Pharmacol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40178335 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/psp4.70028 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 822 Titles: – TitleFull: Harnessing Open-Source Solutions: Insights From the First Open Systems Pharmacology (OSP) Community Conference. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Dallmann A – PersonEntity: Name: NameFull: Feick D – PersonEntity: Name: NameFull: Balazki P – PersonEntity: Name: NameFull: Benamara S – PersonEntity: Name: NameFull: Burghaus R – PersonEntity: Name: NameFull: Chenel M – PersonEntity: Name: NameFull: Choi SL – PersonEntity: Name: NameFull: Cordes H – PersonEntity: Name: NameFull: Guimarães M – PersonEntity: Name: NameFull: Hamadeh A – PersonEntity: Name: NameFull: Ince I – PersonEntity: Name: NameFull: Job KM – PersonEntity: Name: NameFull: Kanacher T – PersonEntity: Name: NameFull: Kovar A – PersonEntity: Name: NameFull: Kuepfer L – PersonEntity: Name: NameFull: Lippert J – PersonEntity: Name: NameFull: Macente J – PersonEntity: Name: NameFull: Nauwelaerts N – PersonEntity: Name: NameFull: Niederalt C – PersonEntity: Name: NameFull: Peters S – PersonEntity: Name: NameFull: Proença S – PersonEntity: Name: NameFull: Sato M – PersonEntity: Name: NameFull: Schaller S – PersonEntity: Name: NameFull: Schlender JF – PersonEntity: Name: NameFull: Schneider A – PersonEntity: Name: NameFull: Sjögren E – PersonEntity: Name: NameFull: Solodenko J – PersonEntity: Name: NameFull: Staab A – PersonEntity: Name: NameFull: Vrenken P – PersonEntity: Name: NameFull: Wendl T – PersonEntity: Name: NameFull: de Witte WEA – PersonEntity: Name: NameFull: Teutonico D IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2025 May Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2163-8306 Numbering: – Type: volume Value: 14 – Type: issue Value: 5 Titles: – TitleFull: CPT: pharmacometrics & systems pharmacology Type: main |
| ResultId | 1 |